Michelle Rosen, NP
Family · Fairfax, VANPI 1184117376
Payments from drug & device makers
Across 59 payments — averaging $53.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Incyte Corporation$143
- Bristol Myers Squibb$113
- Lilly USA, LLC$97
- Daiichi Sankyo Inc.$87
- Johnson & Johnson$52
- plus $221 from 8 others
What the payments were for
- Food & beverage$75824%
- Education$1806%
- Other$2,19670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 35 | $2,420 |
| Incyte Corporation | 3 | $143 |
| Bristol Myers Squibb | 4 | $113 |
| Lilly USA, LLC | 2 | $97 |
| Daiichi Sankyo Inc. | 4 | $87 |
| Johnson & Johnson | 2 | $52 |
| Merck | 2 | $41 |
| AbbVie | 1 | $35 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $35 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| Gilead | 1 | $23 |
| AstraZeneca | 1 | $23 |
| Beigene USA, Inc. | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $19 |
How this compares
$3,135 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 21 | $334,758 |
| VeozahFezolinetant | 12 | $6,259 |
| Letrozole | 70 | $3,181 |
| Anastrozole | 101 | $2,201 |
| Exemestane | 23 | $1,990 |
Paid to pharmacies, not to this prescriber.
Other family in Fairfax
- Meagan AdamsonFairfax$34K
- Christine HelouFairfax$28K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.